Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 9 Overweight 4 Obesity 4 Neoplasms 4 Prostatic Neoplasms 3 Motor Activity 3 Colorectal Neoplasms 3 Sleep Wake Disorders 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Lymphoma 2 Leukemia 2 Hematopoietic and Lymphoid System Neoplasm 2 Hematologic Neoplasms 2 Fatigue 2 Colonic Neoplasms 2 Weight Loss 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Cancer, Papillary 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Obesity-Related Malignant Neoplasm 1 No Evidence of Disease 1 Neoplasm Metastasis 1 Metastatic Pancreatic Adenocarcinoma 1 Lung Neoplasms 1 Locally Advanced Head and Neck Squamous Cell Carcinoma 1 Leukemia, Myeloid, Acute 1 Kidney Neoplasms 1

Interventions

anamorelin 1 alkaloid GB18 1 Standard of Care 1 Retrospective Studies 1 Olanzapine 1 Ibuprofen 1 Fecal Microbiota Transplantation 1 Enteral Nutrition 1 Dietary Supplements 1 Counseling 1 Carnitine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Cachexia × Counseling × 1 year × Clear all

NCT02330926 2025-08-29

MENAC

Norwegian University of Science and Technology

Phase 3 Completed

Cachexia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡